Shares of Acura Pharmaceuticals (ACUR +43%) soar after launching Nexafed, a pseudoephedrine...

|About: Acura Pharmaceuticals, Inc. (ACUR)|By:, SA News Editor

Shares of Acura Pharmaceuticals (ACUR +43%) soar after launching Nexafed, a pseudoephedrine product that provides nasal-congestion relief with a unique technology that disrupts the conversion of pseudoephedrine into the dangerous drug, methamphetamine. Nexafed is now available to national and regional drug wholesalers and will be available to pharmacies soon. The stock has been volatile leading up to today's release, a few weeks ago the stock jumped nearly 50% on reports of the drugs imminent availability.